Skip to main content
Premium Trial:

Request an Annual Quote

Saphetor, Genomenon Agree to Share Genomic Variant Data

CHICAGO (GenomeWeb) – Swiss precision medicine analysis company Saphetor and US-based genomic literature search engine Genomenon have announced a deal to share genomic variant information between their data platforms.

The companies said today that results from the Genomenon Mastermind genomic search engine now include links to Saphetor's VarSome genomic annotation tool. In turn, VarSome, which contains curated data from more than 30 publicly available genomic databases, has Mastermind links to scientific literature related to each variant and gene.

"The VarSome connection in Mastermind provides a richer view and understanding of variant data that previously wasn't available in our search engine," Mike Klein, CEO of Ann Arbor, Michigan-based Genomenon, said in a statement. "Linking the two products provides this mutual benefit to our users, and it was an easy decision on our part to collaborate on this project."

Andreas Massouras, CEO of Lausanne-based Saphetor, also touted the mutual benefits of the partnership. "Having an index into the complete corpus of scientific literature available to our VarSome users significantly enhances the value for VarSome users," he said.

This news comes less than three weeks after Saphetor released an application programming interface to VarSome.

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.